Lonnie Hill

Led strategic finance, pricing, forecasting, and business partnering for biosecurity commercial and R&D teams, shaping scalable processes, setting financial rhythm, and creating models supporting program assessment and operational decisions. Built pricing logic for new offerings, designed KPI dashboards to evaluate program performance, produced short-term and long-term forecasts, and carried out analyses to improve efficiency and cost structure.

Served as business partner to Commercial Officer, Tech Ops, and global commercial leadership during commercial scale-up. Supported commercial and G&A functions, developed gross-to-net assumptions with market access, executed capital forecasting for buildout of new lab space, implemented commercial finance cadence, contributed to incentive compensation committee, and worked with internal teams regarding revenue stemming from partnerships.

Directed financial planning structure and cadence for clinical-stage biotech, building team capability, establishing forecasting rhythm, and managing communication with commercial, medical, manufacturing, and R&D functions. Oversaw enterprise budgeting, cash forecasting, and scenario analysis during pre-commercial phase and guided modeling of operating runway, cost structure, and break-even timing for CFO.

Added value as Chief of Staff to Business Partner for global commercial organization, coordinating monthly performance communication, budget vs. analysis, price-volume-mix, and trend analysis. Led cross-functional regional teams to improve processes, standardize reporting, and support consolidation of commercial results.

Led enterprise financial performance across R&D, commercial, and G&A, overseeing management reporting and variance analysis on monthly, quarterly, and annual basis. Consolidated operating inputs, secured early reads before close, partnered with investor relations on board materials and external messaging, and coordinated finance integration of acquired clinical-stage company. Supported development of annual operating plan across business functions. Modeled OPEX impacts of clinical trial enrollment and supported integration of newly acquired clinical-stage company.

Served as business partner to global marketing teams, overseeing budgeting for $100M across multiple groups. Supported marketing strategy through ROI modeling, investment evaluation, forecasting, variance analysis, and multi-year OPEX and cash flow planning. Partnered with channel sales, business strategy, accounting, and senior finance leaders to inform financial decisions and drive visibility into performance.

Joined full-time after internship and supported management reporting, monthly close, and business planning for 3 business units generating $1B+ in earnings. Managed operating expense analysis for segment exceeding $10B and gained broad finance exposure across reporting, planning, and performance evaluation. Rotated through various areas of business during MBA program. Worked in Houston, TX, Los Angeles, CA, Bangkok, Thailand, and San Ramon, CA.

Advised on multimillion-dollar investments for $30B fixed income asset manager. Built models and generated reports to evaluate creditworthiness and relative value of bond issuances. Authored credit reports for third-party mandates, which generated $15,000 in fees per report.